Cost & Savings
The amount you pay for HUMIRA can depend on a number of factors, including your access to prescription drug coverage, the type of insurance you have, and even the level of coverage your insurance may provide.
This page provides information that can help you determine how much HUMIRA may cost for you, as well as financial support programs that may be able to help you afford your medication.
On this page
HUMIRA List Price
The list price, also known as the Wholesale Acquisition Cost (WAC), for a 4-week supply of HUMIRA*, is $6,922.62 as of January 2023. The WAC may not reflect the price paid by patients.
Call 1.800.4HUMIRA (1.800.448.6472) to find out how much HUMIRA will cost for you.
*HUMIRA 40 mg every other week. Monthly costs and dosing may vary depending on your condition.
Insurance Information†
If you have:
You could pay:
Commercial Insurance (usually provided by an employer)
$0 per month† with the HUMIRA Complete Savings Card
Medicaid
$20.00 or less per month, depending on state plan.
Medicare Part D
$346.00‡-$2,109.00 or less per month, depending on coverage phase
‡Represents catastrophic phase HUMIRA cost.
Monthly out-of-pocket cost for HUMIRA may vary depending on patient's other medication costs.
Most Medicare patients have Standard Part D prescription coverage, which has different costs depending on deductibles and coverage gaps. An Insurance Specialist can help you understand what these costs mean to you, by calling 1.800.4HUMIRA (1.800.448.6472).
Starting January 1st, 2025, Medicare Part D benefits will change to help patients better afford their medication:
- Everyone with Medicare Part D prescription drug coverage will pay no more than $2,000 per year in covered out-of-pocket (OOP) costs. This includes the cost of the deductible. You will automatically receive this benefit once you are enrolled in a Part D plan.
- You’ll have the option to pay your out-of-pocket drug costs in the form of monthly payments instead of all at once by signing up for the Medicare Prescription Payment Plan (MPPP) through your Part D plan. To sign up for the MPPP, you must contact your Medicare Part D plan. They will help you complete the MPPP application process.
Visit www.medicare.gov to learn more about the new Medicare Prescription Payment Plan.
Medicare Low Income Subsidy (LIS)
$10.35 per month starting January 1, 2023
Other Insurance (VA, DOD, Tricare, others)
Because coverage varies by plan, call 1.800.4HUMIRA (1.800.448.6472) to speak to an Insurance Specialist to find out how much HUMIRA will cost for you.
Uninsured or having difficulty paying for your medication
myAbbVie Assist provides AbbVie medicines to qualifying patients. Visit
AbbVie.com/PatientAccessSupport or call 1.800.222.6885 to learn more.
†Important Details About Understanding Your Individual Costs:
The chart above provides cost information based on what a person with the type of coverage listed may pay for two (2) 40 mg doses of HUMIRA, which is generally a 4-week supply. Dosing varies by condition, so your cost may be higher for the first month or on an ongoing basis. Your type of health or prescription insurance plan will determine exactly how much you will pay. Information listed is accurate as of January 2023 and is based on publicly available benefit design information for Medicaid and Medicare Part D out-of-pocket costs for 2023 plan year.
Insurance Coverage Support
To help you understand your coverage and what your out-of-pocket costs may be, it’s important to verify benefits
And even if your HUMIRA isn’t covered, there may be ways to save on your prescription. An Insurance Specialist can talk you through your coverage and help identify potential savings options – regardless of your insurance coverage.
For insurance questions or to verify your benefits, call 1.800.4HUMIRA (1.800.448.6472)
With the HUMIRA Complete Savings Card, you could pay $0 a month*
The HUMIRA Complete Savings Card can make prescription cost as little as $0 a month for eligible patients with commercial insurance.
Find out how you can start saving today!
*For eligible, commercially insured patients. Please see Terms and Conditions here.
myAbbVie Assist
If you are having difficulty paying for your medicine, myAbbVie Assist may be able to help.
myAbbVie Assist, our patient assistance program, provides AbbVie medicine to qualifying patients. It is intended for people that live in the United States, have limited or no health insurance coverage and demonstrate qualifying financial need.
Visit AbbVie.com/PatientAccessSupport to learn more.
‡ Terms and Conditions apply. This benefit covers HUMIRA® (adalimumab) alone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide, or hydroxychloroquine. Eligibility: Available to patients with commercial insurance coverage for HUMIRA who meet eligibility criteria. Co-pay assistance program is not available to patients receiving reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the HUMIRA Complete Savings Card and patient must call HUMIRA Complete at 1-800-4HUMIRA to stop participation. By enrolling in the co-pay assistance program, you agree that this program is intended solely for the benefit of you, the patient. Some health plans have established programs referred to as “accumulator adjustment” or “co-pay maximizer” programs. An accumulator adjustment program is one in which payments made by you that are subsidized by manufacturer assistance do not count toward your deductibles and other out-of-pocket cost sharing limitations. Co-pay maximizers are programs in which the amount of your out-of-pocket costs is increased to reflect the availability of support offered by a manufacturer assistance program. Except where prohibited by applicable state law, if your insurance company or health plan implements either an accumulator adjustment or co-pay maximizer program, you will not be eligible for, and agree not to use, co-pay assistance because these programs are inconsistent with our agreed intent that this program is solely for your benefit. You also agree that you are personally responsible for paying any amount of co-pay required after the savings card is applied. Any out-of-pocket costs remaining after the application of the savings card may not be paid by your health plan, pharmacy benefit programs, or any other program. If you learn your insurance company or health plan has implemented either an accumulator adjustment program or a co-pay maximizer program, you agree to inform AbbVie of this fact by calling 1-800-4HUMIRA to discuss alternative options that may be available to support you. Since you may be unaware whether you are subject to a co-pay maximizer program when you enroll in the co-pay assistance program, AbbVie will monitor program utilization data and reserves the right to discontinue co-pay assistance at any time if AbbVie determines that you are subject to a co-pay maximizer program. For such patients, except where prohibited by applicable state law, AbbVie may discontinue the availability of co-pay support at an amount not to exceed $4,000.00. This amount is subject to change without notice. If your health plan removes HUMIRA from a co-pay maximizer program, you will return to eligibility for co-pay assistance up to the maximum annual benefit listed below. Subject to all other terms and conditions, the maximum annual benefit that may be available solely for the patient’s benefit under the co-pay assistance program is $14,000 per calendar year. The actual application and use of the benefit available under the co-pay assistance program may vary on a monthly, quarterly, and/or annual basis depending on each individual patient’s plan of insurance and other prescription drug costs. This co-pay assistance program is subject to change, reduction in monetary amount, or discontinuation without any notice. AbbVie in its sole discretion may unilaterally reduce or discontinue the maximum annual benefit for any reason. Except where prohibited by applicable law, this includes potential reduction or discontinuation to ensure that co-pay assistance is utilized solely for the patient’s benefit. Patients may not seek reimbursement for value received from the Humira Complete Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This assistance offer is not health insurance. By utilizing this co-pay assistance program, you hereby accept and agree to abide by these terms and conditions. Any individual or entity who enrolls or assists in the enrollment of a patient in the co-pay assistance program represents that the patient meets the eligibility criteria and other requirements described herein. Further, you agree that you currently meet the eligibility criteria and other requirements described herein every time you use the co-pay assistance program. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.